Proathlete Wealth Management »

Biogen Idec shares owned by Proathlete Wealth Management

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Proathlete Wealth Management from 13F filings

Historical chart of Proathlete Wealth Management investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Proathlete Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Proathlete Wealth Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $357k 1.8k 193.84
2024-06-30 $428k 1.8k 231.82
2024-03-31 $413k 1.9k 215.63
2023-12-31 $498k 1.9k 258.77

More positions owned by Proathlete Wealth Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core Msci Eafe (IEFA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Rus 1000 Val Etf (IWD)
American Centy Etf Tr Avantis Us Mid C (AVMC)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Ishares U S Etf Tr Blackrock Sh Dur (NEAR)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr 3 7 Yr Treas Bd (IEI)
Microsoft Corporation (MSFT)
Ishares Tr National Mun Etf (MUB)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)

View all positions for Proathlete Wealth Management

Top funds holding Biogen Idec

Vanguard Group
PRIMECAP Management Company
BlackRock
BlackRock
State Street Corporation
Jpmorgan Chase & Co
T. Rowe Price Investment Management
Geode Capital Management
T. Rowe Price Associates
Beutel, Goodman & Company
Invesco
Morgan Stanley
Goldman Sachs Group
Northern Trust
RA Capital Management

View all funds holding Biogen Idec